Literature DB >> 24451949

Construction of the Chinese Veteran Clinical Research (CVCR) platform for the assessment of non-communicable diseases.

Jiping Tan1, Nan Li2, Jing Gao3, Yuhe Guo4, Wei Hu4, Jinsheng Yang5, Baocheng Yu6, Jianmin Yu7, Wei Du8, Wenjun Zhang9, Lianqi Cui10, Qingsong Wang11, Xiangnan Xia12, Jianjun Li13, Peiyi Zhou14, Baohe Zhang15, Zhiying Liu16, Shaogang Zhang17, Lanying Sun18, Nan Liu19, Ruixiang Deng20, Wenguang Dai21, Fang Yi22, Wenjun Chen23, Yongqing Zhang24, Shenwu Xue25, Bo Cui1, Yiming Zhao2, Luning Wang26.   

Abstract

BACKGROUND: Based on the excellent medical care and management system for Chinese veterans, as well as the detailed medical documentation available, we aim to construct a Chinese Veteran Clinical Research (CVCR) platform on non-communicable diseases (NCDs) and carry out studies of the primary disabling NCDs.
METHODS: The Geriatric Neurology Department of Chinese People's Liberation Army General Hospital and veterans' hospitals serve as the leading and participating units in the platform construction. The fundamental constituents of the platform are veteran communities. Stratified typical cluster sampling is adopted to recruit veteran communities. A cross-sectional study of mental, neurological, and substance use (MNS) disorders are performed in two stages using screening scale such as the Mini-Mental State Examination and Montreal cognitive assessment, followed by systematic neuropsychological assessments to make clinical diagnoses, evaluated disease awareness and care situation.
RESULTS: A total of 9 676 among 277 veteran communities from 18 cities are recruited into this platform, yielding a response rate of 83.86%. 8 812 subjects complete the MNS subproject screening and total response rate is 91.70%. The average participant age is (82.01±4.61) years, 69.47% of veterans are 80 years or older. Most participants are male (94.01%), 83.36% of subjects have at least a junior high school degree. The overall health status of veterans is good and stable. The most common NCD are cardiovascular disorders (86.44%), urinary and genital diseases (73.14%), eye and ear problems (66.25%), endocrine (56.56%) and neuro-psychiatric disturbances (50.78%).
CONCLUSION: We first construct a veterans' comprehensive clinical research platform for the study of NCDs that is primarily composed of highly educated Chinese males of advanced age and utilize this platform to complete a cross-sectional national investigation of MNS disorders among veterans. The good and stable health condition of the veterans could facilitate the long-term follow-up studies of NCDs and provide prospective data to the prevention and management of NCDs.

Entities:  

Mesh:

Year:  2014        PMID: 24451949

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Associations of particulate matter with dementia and mild cognitive impairment in China: A multicenter cross-sectional study.

Authors:  Jiping Tan; Nan Li; Xiaoxiao Wang; Gongbo Chen; Lailai Yan; Luning Wang; Yiming Zhao; Shanshan Li; Yuming Guo
Journal:  Innovation (Camb)       Date:  2021-07-21

2.  Do physical exercise and reading reduce the risk of Parkinson's disease? a cross-sectional study on factors associated with Parkinson's disease in elderly Chinese veterans.

Authors:  Y M Zou; J P Tan; N Li; J S Yang; B C Yu; J M Yu; Y M Zhao; L N Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-16       Impact factor: 2.570

3.  Physical activity as a protective factor against depressive symptoms in older Chinese veterans in the community: result from a national cross-sectional study.

Authors:  Wen-Jin Du; Ji-Ping Tan; Fang Yi; Yong-Ming Zou; Ya Gao; Yi-Ming Zhao; Lu-Ning Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-23       Impact factor: 2.570

4.  Awareness Status of Chronic Disabling Neurological Diseases among Elderly Veterans.

Authors:  Ji-Ping Tan; Lin-Qi Zhu; Jun Zhang; Shi-Min Zhang; Xiao-Yang Lan; Bo Cui; Yu-Cheng Deng; Ying-Hao Li; Guang-Hua Ye; Lu-Ning Wang
Journal:  Chin Med J (Engl)       Date:  2015-05-20       Impact factor: 2.628

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.